Completed PHASE1 INTERVENTIONAL 3-arm NCT01084473

Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit (GADEX)

Effect of Dexmedetomidine Infusion on Gastric Emptying and Gastrointestinal Transit in Healthy Volunteers

Sponsor: University of Helsinki

Interventions Dexmedetomidine Morphine Placebo

Updated 6 times since 2017 Last updated: Jun 3, 2010 Started: Mar 31, 2010 Primary completion: Jun 30, 2010 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Gastric Emptying and Healthy and is currently completed. University of Helsinki leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Apr 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Apr 2020 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Helsinki
University of Turku

Data source: University of Turku

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Turku, Finland